Review:
Ema Pharmacovigilance System
overall review score: 4.5
⭐⭐⭐⭐⭐
score is between 0 and 5
The European Medicines Agency (EMA) Pharmacovigilance System is a framework for monitoring and assessing the safety of medicines throughout their lifecycle.
Key Features
- Monitoring adverse drug reactions
- Assessing risks and benefits of medicines
- Implementing risk minimization measures
- Communicating safety information to healthcare professionals and patients
Pros
- Enhances patient safety by ensuring timely detection and management of adverse drug reactions
- Promotes transparency by providing safety information to healthcare professionals and patients
- Helps in making informed decisions on the use of medicines based on the latest safety data
Cons
- Resource-intensive to maintain and operate
- Challenges in timely reporting and analysis of adverse events